Overview

A Study of LY2624803 in Japanese Participants With Transient Insomnia

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to learn how different doses of LY2624803 affect sleep in healthy Japanese participants. The study has four treatment periods. Participants will receive a single dose of LY2624803 or placebo in each treatment period.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Pharmaceutical Solutions